TuisSYK • NYSE
add
Stryker Corp
Vorige sluiting
$364,92
Dagwisseling
$364,27 - $370,21
Jaarwisseling
$329,16 - $406,19
Markkapitalisasie
141,08 mjd USD
Gemiddelde volume
1,39 m
P/V-verhouding
48,81
Dividend-opbrengs
0,91%
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Jun. 2025info | J/J-verandering |
---|---|---|
Inkomste | 6,02 mjd | 11,07% |
Bedryfskoste | 2,59 mjd | 11,87% |
Netto inkomste | 884,00 m | 7,15% |
Netto winsgrens | 14,68 | -3,55% |
Wins per aandeel | 3,13 | 11,39% |
EBITDA | 1,62 mjd | 15,00% |
Effektiewe belastingkoers | 12,99% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Jun. 2025info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 2,46 mjd | 25,91% |
Totale bates | 46,33 mjd | 18,40% |
Totale aanspreeklikheid | 25,14 mjd | 29,80% |
Totale ekwiteit | 21,19 mjd | — |
Uitstaande aandele | 382,31 m | — |
Prys om te bespreek | 6,58 | — |
Opbrengs op bates | 7,16% | — |
Opbrengs op kapitaal | 8,63% | — |
Kontantvloei
Netto kontantverandering
(USD) | Jun. 2025info | J/J-verandering |
---|---|---|
Netto inkomste | 884,00 m | 7,15% |
Kontant van bedrywe | 1,11 mjd | 75,51% |
Kontant van beleggings | -104,00 m | 11,11% |
Kontant van finansiering | -989,00 m | -2,38% |
Netto kontantverandering | 55,00 m | 112,06% |
Beskikbare kontantvloei | 1,02 mjd | 79,44% |
Meer oor
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
Gestig
1941
Hoofkwartier
Webwerf
Werknemers
53 000